Page 62 - Read Online
P. 62

Page 6 of 14                                    Schwertheim et al. Hepatoma Res 2020;6:41  I  http://dx.doi.org/10.20517/2394-5079.2020.23


                                         Table 2. NGS study: CTNNB1 mutations in the HCC cohort 1
                                         Gene     AA mutation Cosmic_v70  n cases (%)
                                         CTNNB1 2        D32G           1/72 (1.4%)
                                         CTNNB1 2        D32N           1/72 (1.4%)
                                         CTNNB1 2        D32V           0/72 (0%)
                                         CTNNB1 2        D32Y           3/72 (4.2%)
                                         CTNNB1          S33A           1/72 (1.4%)
                                         CTNNB1 2        S33C           3/72 (4.2%)
                                         CTNNB1 2        S33F           2/72 (2.8%)
                                         CTNNB1 2        G34E           1/72 (1.4%)
                                         CTNNB1          G34R           1/72 (1.4%)
                                         CTNNB1 2        G34V           1/72 (1.4%)
                                         CTNNB1          I35S           1/72 (1.4%)
                                         CTNNB1          H36P           1/72 (1.4%)
                                         CTNNB1          S37A           1/72 (1.4%)
                                         CTNNB1 2        S37Y           1/72 (1.4%)
                                         CTNNB1 2        T41A           1/72 (1.4%)
                                         CTNNB1 2        T41I           2/72 (2.8%)
                                         CTNNB1 2        S45P           2/72 (2.8%)
                                         CTNNB1 2        S45Y           1/72 (1.4%)
                                         CTNNB1          K335T          1/72 (1.4%)
                                         CTNNB1          N387K          2/72 (2.8%)
                                                                    2
               1 All mutations found in COSMIC with the prevalence of minimum 5% are listed;  mutations listed additionally in the ClinVar database

               intranuclear inclusion with positive immunoreactivity was analyzed for β-catenin and KDM2A. We detected
               in 19 of 72 (26.4%) HCCs at least one membrane-bounded intranuclear inclusion with positive β-catenin
               immunostaining; for KDM2A 19 of 71 (26.8%) valid HCC cases showed at least one membrane-bounded
               intranuclear inclusion with positive immunostaining. β-catenin immunohistochemistry was available for all
               cases (72/72) while for KDM2A, suitable material for immunohistochemistry was available in 71 of 72 cases.

               NGS study of CTNNB1 mutations
               To clarify the reason for the high number of NI containing β-catenin, we investigated HCCs with possible
               mutations of the β-catenin gene CTNNB1 by NGS. We found up to twenty different CTNNB1 mutations in
               our cases. We have listed all mutations found in COSMIC with a prevalence of at least 5%. The mutations that
               are also recorded in the ClinVar database are marked [Table 2]. Chi-square cross table analysis of the HCC
               cases demonstrated that a positive CTNNB1 mutation status was significantly associated with the occurrence
               of positive nuclear β-catenin immunostaining (P ≤ 0.001). Additionally, we performed cross table analysis
               to examine a possible association between the occurrence of NI and the presence of CTNNB1 mutations; no
               significant association was found.

               TEM analysis of NI
               We performed ultrastructural analysis in order to investigate the content and shape of NI in more detail
               [Figure 2]. Our TEM studies showed that NI in HCC in most cases was completely enclosed by the nuclear
               membrane. NI contained degenerated cell material, lysosomes and heterolysosomes. In general, the content
               of the inclusions had a higher electron density than the cytoplasm, suggesting that NI are not simply passive
               invaginations of the cytoplasm into the nucleus [Figure 2].


               Immunohistochemical analysis of NI
               Association of β-catenin with autophagy-associated proteins in NI
               We analysed NI by immunohistochemistry to clarify whether there was an association between the
               occurrence of intranuclear inclusions with β-catenin immunopositivity and autophagy [Figure 3]. Recently,
               we have examined the autophagy-associated proteins p62, ubiquitin, LC3B, cathepsin B and cathepsin D
   57   58   59   60   61   62   63   64   65   66   67